Estimating the cost of complications of diabetes in Australia using administrative health-care data

被引:60
作者
Clarke, Philip [1 ]
Leal, Jose [2 ]
Kelman, Chris [3 ,4 ]
Smith, Merran [5 ]
Colagiuri, Stephen [6 ]
机构
[1] Univ Sydney, Dept Publ Hlth, Sydney, NSW 2006, Australia
[2] Univ Oxford, Hlth Econ Res Ctr, Oxford, England
[3] Australian Natl Univ, Sch Med, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia
[4] Australian Natl Univ, Sch Med, Canberra, ACT, Australia
[5] Dept Hlth WA, Perth, WA, Australia
[6] Prince Wales Hosp, Dept Endocrinol, Randwick, NSW 2031, Australia
基金
英国医学研究理事会;
关键词
Australia; diabetes mellitus; diabetes-related complications; health-care costs; record linkage;
D O I
10.1111/j.1524-4733.2007.00228.x
中图分类号
F [经济];
学科分类号
02 ;
摘要
Objective: To estimate Australian health-care costs in the year of first occurrence and subsequent years for major diabetes-related complications using administrative health-care data. Methods: The costs were estimated using administrative information on hospital services and primary health-care services financed through Australia's national health insurance system Medicare. Data were available for 70,340 patients with diabetes in Western Australia (mean duration of 4.5 years of follow-up). Multiple regression analysis was used to estimate inpatient and primary care costs. Results: For a man aged 60 years, the average costs in the year the event first occurred were: amputation $20,416 (95% CI 18,670-22,411); nonfatal myocardial infarction (MI) $11,660 (10,931-12,450); nonfatal stroke $14,012 (12,849-15,183); ischaemic heart disease $12,577 (12,026-13,123); heart failure $15,530 (13,965-17,009); renal failure $28,661 (22,989-34,202); and chronic leg ulcer $15,413 (13,089-18,123). The costs in subsequent years for a man aged 60 years range from 14% for nonfatal MI to 106% for renal failure, of event costs. Conclusions: Estimates of the health-care costs associated with diabetes-related complications can be used in modeling the long-term costs of diabetes and in evaluating the cost-effectiveness of improving care.
引用
收藏
页码:199 / 206
页数:8
相关论文
共 25 条
[1]  
[Anonymous], 2000, Handbook of Health Economics
[2]  
*AUSTR BUR STAT, 2001, CENS BAS COMM PROF S
[3]  
Australian Bureau of Statistics, 2005, CONS PRIC IND AUSTR
[4]   Estimating marginal and incremental effects on health outcomes using flexible link and variance function models [J].
Basu, A ;
Rathouz, PJ .
BIOSTATISTICS, 2005, 6 (01) :93-109
[5]   The impact of diabetes-related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65) [J].
Clarke, P ;
Gray, A ;
Legood, R ;
Briggs, A ;
Holman, R .
DIABETIC MEDICINE, 2003, 20 (06) :442-450
[6]   Factors influencing the cost of hospital care for people with diabetes in Australia [J].
Clarke, Philip ;
Kelman, Chris ;
Colagiuri, Stephen .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2006, 20 (06) :349-355
[7]   Cost-utility analyses of intensive blood glucose and tight blood pressure control in type 2 diabetes (UKPDS 72) [J].
Clarke, PM ;
Gray, AM ;
Briggs, A ;
Stevens, RJ ;
Matthews, DR ;
Holman, RR .
DIABETOLOGIA, 2005, 48 (05) :868-877
[8]   A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) [J].
Clarke, PM ;
Gray, AM ;
Briggs, A ;
Farmer, AJ ;
Fenn, P ;
Stevens, RJ ;
Matthews, DR ;
Stratton, IM ;
Holman, RR .
DIABETOLOGIA, 2004, 47 (10) :1747-1759
[9]  
*COMM DEP HLTH AG, 1999, REP NAT HOSP COST DA
[10]  
*COMM DEP HLTH FAM, 1998, DEV AUSTR REF DIAGN, V1